In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 131052-47-6, name is (3,5-Dimethylisoxazol-4-yl)methanamine, introducing its new discovery. Recommanded Product: 131052-47-6
PYRIDAZINE DERIVATIVES FOR INHIBITING BETA AMYLOID PEPTIDE PRODUCTION
The present invention relates to novel compounds that inhibit the production of beta-amyloid peptide (1-42), processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated beta-amyloid levels or beta-amyloid deposits, particularly Alzheimer’s disease
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 131052-47-6, and how the biochemistry of the body works.Recommanded Product: 131052-47-6
Reference：
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem